PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer - PDS Biotechnology (NASDAQ:PDSB)

PRINCETON, N.J., Jan. 22, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) ("PDS Biotech" or "the Company"), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer

Related Keywords

United States ,Gina Cestari ,Laurenv Wood ,Frank Bedu ,Kirk Shepard ,Kirkv Shepard ,University Of Cincinnati Medical School ,Global Medical Affairs At Takeda Pharmaceuticals International ,Department Of Hematology ,Biotechnology Corporation The Company ,Global Medical Affairs At Baxter International Inc ,Exchange Commission ,Scientific Affairs At Boehringer Ingelheim Pharmaceuticals Inc ,Twitter ,Biotechnology Corporation ,Case Western Reserve University ,Cornell University ,Merck Co Inc ,Affairs Professional Society ,Cleveland Clinic Foundation ,University Of Chicago Hospitals ,United States Securities Exchange ,Chief Medical Officer ,Frank Bedu Addo ,Chief Executive Officer ,Senior Vice President ,Global Medical Affairs Oncology Business Group ,Eisai Pharmaceutical ,Medical Affairs Professional Society ,Global Medical Affairs ,Baxter International Inc ,Takeda Pharmaceuticals International ,Vice President ,Scientific Affairs ,Boehringer Ingelheim Pharmaceuticals ,Medical Oncology ,Cincinnati Medical ,Chicago Hospitals ,Nasdaq Listing Rule ,United States Securities Exchange Act ,United States Securities Act ,Financial Condition ,Merck Sharp ,